Bristol-myers Squibb Compnay

Rushith Kumar Anumula

Alaric J Dyckman

Sreekantha Ratna Kumar

Christopher P Mussari

Laxman Pasunoori

Subramanya Hegde

Dharmpal S Dodd

Trevor C Sherwood

Brian K Whiteley

John L Gilmore

Srinivasan Kunchithapatham Duraisamy

Pitani Veera Venkata Srinivas

Shoshana L Posy

Tasir Shamsul Haque

Wei Meng

Ramesh Kumar Sistla

Susheel Jethanand Nara

Guohua Zhao

Yanting Huang

Srinivas Cheruku

Elizabeth Anne Jurica

David S Yoon

Anupama Kandhi Ramachandra Reddy

Ximao Wu

Rishikesh Narayan

Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R, R, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.

Substituted indole compounds useful as TLR inhibitors

4-azaindole compounds

N-oxides, or salts thereof, wherein G, L, R, R, R, R, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases. 

Amide substituted indole compounds useful as TLR inhibitors

Disclosed are compounds of Formula (I) or salts thereof, wherein A, G, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases. 

Aryl and heteroaryl substituted indole compounds

4-Azaindole compounds

The present invention provides compounds of Formula (I): 

Bridged bicyclic compounds as farnesoid X receptor modulators

Growing community of inventors

Secunderabad, India

Rushith Kumar Anumula